| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.65 | 0.0003 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.2 | 0.0004 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.43 | 0.0005 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |